Birchtech Corp. (AMEX: BCHT), a cleantech company specializing in sustainable air and water treatment solutions, has completed its uplisting to the NYSE American exchange from the over-the-counter market. This move follows a reverse stock split and a public offering of approximately 6.25 million shares of common stock at an assumed price of $2.40 per share, totaling about $15 million based on the last reported sale price on January 9, 2026. The company's board of directors approved a 1-for-5 reverse stock split in late December to improve the stock price and support the uplisting, with President & CEO Richard MacPherson stating it would enhance the company's capital market profile and access to institutional capital.
The uplisting coincides with Birchtech receiving a final judgment in a patent lawsuit dating back to July 2019, which is expected to reach $78 million, up from an initial award of $57 million. This settlement, combined with the capital raised from the stock sale, provides the company with significant resources to fund expansion in the water purification market and increase market share across the U.S. coal-fired power fleet. Birchtech reports that its market share could double over the next few years as it establishes business relationships with utilities using its patented technologies for mercury emissions capture, potentially leading to new licenses and supply contracts typically lasting 3-5 years.
In its water treatment business, Birchtech has secured purchase orders totaling $0.9 million from a mid-Atlantic power utility after three years of development and innovation. The company has also partnered with Civil & Environmental Consultants Inc. (CEC) to provide testing services to utility customers and maintains a pipeline of potential water treatment projects. This expansion addresses growing concerns about water utilities needing more effective and affordable methods to remove contaminants, including harmful "forever chemicals" like PFAS, which are linked to health issues such as low birth rates, increased cancer risks, and high blood pressure in pregnant women. More information on Birchtech's developments can be found at https://www.newmediawire.com.
With a potential $78 million settlement and $20 million from the offering, Birchtech is positioned to leverage demand for cleaner air and water, aiming to attract increased investor attention in 2026 as it scales its operations and strengthens its financial standing. The company's focus on sustainable solutions in critical environmental sectors underscores its role in addressing pressing public health and environmental challenges, potentially influencing industry standards and regulatory approaches. For further details on the company's initiatives, visit https://www.benzinga.com.
